menu
Currently, several companies claim to be engaged in the development / manufacturing of various types of autoinjectors
Currently, several companies claim to be engaged in the development / manufacturing of various types of autoinjectors
Currently, several companies claim to be engaged in the development / manufacturing of various types of autoinjectors

Currently, several companies claim to be engaged in the development / manufacturing of various types of autoinjectors

In addition toenabling patients to self-medicate, these devices are designed to ensure safetyduring the dosing process and promote compliance to prescribed therapeuticregimens. Moreover, the adoption of autoinjectors, and other self-injectionproducts, has enabled significant cost savings for end users by eliminating theneed to visit hospitals / out-patient clinics for dosing.

 

To order this 600+page report, which features 360+ figures and 350+ tables, please visit this https://www.rootsanalysis.com/reports/view_document/autoinjectors-market/293.html

 

The USD 2.5 billion(by 2030) financial opportunity within the global autoinjectors market has beenanalyzed across the following segments:

§  Usability

§  Disposable

§  Reusable

§  Route of administration

§  Subcutaneous

§  Intramuscular

§  Type of molecule

§  Antibody

§  Peptide

§  Protein

§  Small molecule

§  Therapeutic indication

§  Anaphylaxis

§  Diabetes

§  Migraine

§  Multiple sclerosis

§  Rheumatoid arthritis

§  Other indications

§  Key geographical regions

§  North America

§  Europe

§  Asia-Pacific

§  Rest of the World

 

The GlobalAutoinjectors Market (3rdEdition), 2020-2030. report features the following companies, which weidentified to be key players in this domain:

§ Antares Pharma

§ Consort Medical (Previously Bespak)

§ DALI Medical Devices

§ Elcam Medical (E3D Elcam Drug Delivery Devices)

§ Jiangsu Delfu Medical Devices

§ Oval Medical Technologies

§ Owen Mumford

§ SHL Group

§ Union Medico®

§ Ypsomed

 

Table of Contents

 

1. Preface

2. Executive Summary


3. Introduction

4. Primary Drug Containers

5. Autoinjectors: Current Market Landscape

6. Product Competitiveness Analysis

7. Brand Positioning of Key Industry Players

8. Patent Analysis

9. Therapeutic Products Available inAutoinjectors

10. Case Study: Autoinjector-basedCombination Products and Affiliated Therapeutic Areas

11. Likely Drug Candidates for Delivery ViaAutoinjectors

12. Key Players

13. Emerging Players

14. KOL Analysis

 

15. SWOT Analysis

 

16. Case Study: Medical Device Contract ServiceProviders

 

17. Market Sizing and Opportunity Analysis

 

18. Conclusion

 

19. Interview Transcripts

 

20. Appendix 1: Tabulated Data

 

21. Appendix 2: List of Companies and Organizations

 

To purchase a copy, please visit https://www.rootsanalysis.com/reports/view_document/autoinjectors-market/293.html

 

Contact Details

Gaurav Chaudhary

+1 (415) 800 3415

gaurav.chaudhary@rootsanalysis.com